Abstract:BACKGROUND: Standard antibiotic treatment for nontuberculous mycobacteria pulmonary disease (NTMPD) has unsatisfactory success rates. Pulmonary resection is considered adjunctive therapy for patients with refractory disease or severe complications, but surgical indications and extent of resection remain unclear. We present surgical treatment outcomes for NTMPD and analyzes risk factors for unfavorable outcomes. METHODS: We conducted a retrospective investigation of medical records for patients diagnosed with NTMPD who underwent surgical treatment at Asan Medical Center between 2007 and 2021. We analyzed clinical data including microbiological and surgical outcomes. RESULTS: A total of 71 NTMPD patients underwent thoracic surgery. Negative conversion of acid-fast bacillus (AFB) culture following pulmonary resection was observed in 51 (73.9%) patients. In terms of long-term outcomes, negative conversion was sustained in 38 cases (55.1%). Mortality occurred in 7 patients who underwent pulmonary resections for NTMPD. Statistically significant associations with factors for recurrence or non-negative conversion of AFB culture were found in older age (odds ratio [OR] =1.093, 95% confidence interval [CI]: 1.029–1.161, P = 0.004), male sex (OR = 0.251, 95% CI: 0.071–0.892, P = 0.033), and extensive NTMPD lesions involving three lobes or more (OR = 5.362, 95% CI: 1.315–21.857, P = 0.019). Interstitial lung disease (OR = 13.111, 95% CI: 1.554–110.585, P = 0.018) and pneumonectomy (OR = 19.667, 95% CI: 2.017–191.797, P = 0.018) were statistically significant risk factors for postoperative mortality. CONCLUSION: Pulmonary resection can be an effective adjuvant treatment option for NTMPD patients, with post-operative antibiotic treatment as the primary treatment. Careful patient selection is crucial, considering the associated risk factors and resectability due to complications and recurrence.

The experience of Medicine Therapy in 48 cases with Pulmonary Inflammatory Pseudotumor

Diagnosis and Treatment of Pulmonary Inflammatory Pseudotumor

A case of pulmonary inflammatory myofibroblastic tumor treated with bronchoscopic therapy plus lobectomy

Report of 41 Cases with Inflammatory Pseudotumor of the Lung

[Thirteen Cases with Tuberculous Otitis Media and Mastoiditis].

The Diagnosis and Surgical Treatment for 56 Cases with Pulmonary and Pleural Aspergillosis

Misdiagnosis analysis of pulmonary inflammatory pseudotumor

The diagnosis and surgical treatment of imflammatory pseudotumor of lung

Imaging analysis of chest CT of pulmonary inflammatory pseudotumor

Misdiagnosis Analysis and Literature Review: 14 Patients with Pulmonary Inflammatory Pseudotumor

Inflammatory Pseudotumor of the Thymus: A Case Report and Review of the Literature

Treatment, pathological characteristics, and prognosis of pulmonary inflammatory myofibroblastic tumor–a retrospective study of 8 cases

[Diagnosis and Treatment of Primary Pulmonary Mucosa-Associated Lymphoid Tissue Lymphoma].

Pulmonary Nodular Lymphoid Hyperplasia: a Rare Benign Disease with Malignant Mask.

CT Appearances of Pulmonary Inflammatory Pseudotumor and Pripheral Lung Cancer

Photodynamic therapy for Cutaneous inflammatory pseudotumour: A case report

Pulmonary Inflammatory Myofibmblastic Tumor Misdiagnosed As Central Lung Cancer:A Case Report and Literature Review

Clinical experience on surgical treatment of tracheal diseases

Adjuvant surgical resection for nontuberculous mycobacterial pulmonary disease: Effectiveness and complications

Surgical Treatment of Primary Retroperitoneal Tumors:An Analysis of 62 Cases

Surgical Treatment of Multi-Drug Resistant Pulmonary Tuberculosis in 188 Cases